Literature DB >> 2530200

Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear.

K E Rarey1, W G Luttge.   

Abstract

Aldosterone-Type I and dexamethasone-Type II/IB receptor complexes were identified in cytosol prepared from both cochlear and vestibular tissue samples. The specific binding capacity of Type I receptors in the cochlear tissues was approximately equal to that in the vestibular tissues. Likewise, the binding capacity of Type II/IB receptors in the cochlea was approximately equal to that in the vestibular endorgans. Based on the total specific binding measured with dexamethasone, the Type II/IB receptors appeared to outnumber the Type I receptors in cochlear and vestibular tissues by a factor of approximately 2.6; however, when adjustments were made for the probable cross-binding of dexamethasone to Type I receptors, these ratios were decreased to approximately 1.6. The existence of protein receptors for adrenocorticosteroid hormones demonstrated in the present study clearly suggests a mechanism whereby such hormones may directly regulate fluid and ionic gradients in the inner ear.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530200     DOI: 10.1016/0378-5955(89)90013-0

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  13 in total

1.  The mouse cochlea expresses a local hypothalamic-pituitary-adrenal equivalent signaling system and requires corticotropin-releasing factor receptor 1 to establish normal hair cell innervation and cochlear sensitivity.

Authors:  Christine E Graham; Douglas E Vetter
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

3.  A Polymer-Based Extended Release System for Stable, Long-term Intracochlear Drug Delivery.

Authors:  Erik Pierstorff; Shanshan Chen; Maria Paola Chaparro; John M Cortez; Yen-Jung Chen; Su Young Ryu; Sherry M Tsai; Marc M Baum; Wan Wan Yang; Federico Kalinec; Thomas Smith; Stacey Ludwig; William H Slattery
Journal:  Otol Neurotol       Date:  2018-10       Impact factor: 2.311

4.  Prevention of cisplatin-induced hearing loss by extended release fluticasone propionate intracochlear implants.

Authors:  Erik Pierstorff; Wan-Wan Yang; Yen-Jung Angel Chen; Shirley Cheung; Federico Kalinec; William H Slattery
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-03-20       Impact factor: 1.675

Review 5.  The role of glucocorticoids for spiral ganglion neuron survival.

Authors:  David Xu Jin; Zhaoyu Lin; Debin Lei; Jianxin Bao
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

6.  Endolymphatic sodium homeostasis by extramacular epithelium of the saccule.

Authors:  Sung Huhn Kim; Daniel C Marcus
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

7.  Dynamics of Na,K-ATPase sites in lateral cochlear wall tissues of the rat.

Authors:  L M Curtis; W J ten Cate; K E Rarey
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  Expression and dexamethasone-induced nuclear translocation of glucocorticoid and mineralocorticoid receptors in guinea pig cochlear cells.

Authors:  Sung-Hee Kil; Federico Kalinec
Journal:  Hear Res       Date:  2013-02-09       Impact factor: 3.208

9.  Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss.

Authors:  Nezamoddin Berjis; Saeed Soheilipour; Alireza Musavi; Seyed Mostafa Hashemi
Journal:  Adv Biomed Res       Date:  2016-06-20

10.  Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy.

Authors:  Emanuele Ferri; Antonio Frisina; Anna Chiara Fasson; Enrico Armato; Giacomo Spinato; Maurizio Amadori
Journal:  ISRN Otolaryngol       Date:  2012-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.